The conference includes two Conference Rooms; biotech and technologies, both including company presentations.
The Anglonordic Life Science Conference is a popular destination for the majority of European investment firms. 65 investment firms are registered to attend.
4BIO Capital Partners, Advent Life Sciences, Albion Ventures, Angel investor, Arcus Altor Ltd, Arix Bioscience, Barclays, BioCity Group Limited, BioSeed Capital ltd, Caldwell Capital Limited, Cambridge Innovation Capital, Capricorn Venture Partners, CBC Investment Group, Certus, Clubb Capital Ltd, Epidarex Capital, Esperante, European Investment Fund, Fort Rock Capital, GHO Capital, Harbert European Growth Capital, Health Enterprise East, IAG, Ignite Capital Partners, Inc., Industrifonden, Inventages, IP Group PLC, IPF Partners, Johnson & Johnson Innovation, Johnson and Johnson, JPIF, Lilly, Locate in Limburg vzw, LSP, Merck Ventures, Molecular Warehouse, MVM Life Science Partners LLP, NeoMed, NetScientific, New Science Global Healthcare Fund, Newstock Capital, NIHR Office for Clinical Research Infrastructure, Norgine Ventures Management Limited, Novo A/S, O2h Ventures Limited, Pfizer Limited, Rainbow Seed Fund, Royal Bank of Canada (RBC), Ruffena Capital, SBA Ltd, SEHTA, SR One, Stifel, Sunstone Life Science Ventures, Tassi @ Co, Ventac Partners, Wellcome Trust, Wren Capital
Active Needle Technology, Aglaris, Biotec Pharmacon, Brain Stimulation AB, Calcivis, Elasmogen Ltd, EnXray, Glide Technologies, Hiloprobe AB, LINK Medical Research, Macrophage Pharma, MGB Biopharma, MicroQuin, Nanogenic Solutions, OxStem, Predicare AB, ProAxsis, QureTech Bio AB, RefLab, ScioVR, Storm Therapeutics, TRANSPLANT BIOMEDICALS , SL, Tridentify AB, Unguis.